Super Vision

Medical Devices & EquipmentSeries CBeijing, Chinasupervisiontech.cn

Latest round

Series C

Last raised

Mar 2026

Total raised

$22M

Investors

11

About Super Vision

, trading as Super Vision, is an ophthalmology medical device research and development company. It founded by Mr. Lejin Wang, a professor at Peking University people's hospital, and a leader in ophthalmology in China. Super Vision developed four product lines, which are used to cure myopia, glaucoma and pediatric ophthalmology. Its main products are implantable glaucoma micro drainage pump and eye muscle nerve stimulation debugging system. The therapeutic principle of the eye muscle nerve stimulation debugging system is derived from the functional electrical stimulation FES technology. The company generates revenue by developing eye muscle nerve stimulators for congenital nystagmus.

Who invested in Super Vision

11 investors across 4 rounds

See all investors in Super Vision

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Mar 16, 2026

    Amount

    Undisclosed

    Investors

    Locked

  2. Series B

    Feb 25, 2025

    Amount

    Undisclosed

    Investors

    Locked

  3. Series A

    Dec 7, 2022

    Amount

    $14M

    Investors

    Locked

  4. Series A

    Aug 6, 2021

    Amount

    $8.1M

    Investors

    Locked

Questions about Super Vision

Who invested in Super Vision?

Super Vision has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Super Vision raised?

Super Vision has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Super Vision last raise money?

Super Vision's most recent round on record is a Series C, in Mar 2026.

What does Super Vision do?

, trading as Super Vision, is an ophthalmology medical device research and development company.

Where is Super Vision headquartered?

Super Vision is headquartered in Beijing, China.

Which VCs invest in companies like Super Vision?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Super Vision's stage. Their profiles are linked below.

Raising like Super Vision? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.